Table 1

Sample size calculations and magnitude of difference in left ventricular remodeling between treatment groups

Placebo

Δ LVEDV

at 1 year

Perindopril

Δ LVEDV

at 1 year

% Remodeling prevented

+11%

+1%

90%

+11.7%

+1.9%

84%

+12.5%

+2.75%

78%

+14.2%

+4.4%

69%

+15.8%

+6.1%

62%


Pituskin et al. BMC Cancer 2011 11:318   doi:10.1186/1471-2407-11-318

Open Data